乙型肝炎-话题@MedSci

#乙型肝炎#

215篇内容 | 5222人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1825748, encodeId=cc821825e48b3, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=ENYO Pharma发布进行中的两项Vonafexor (EYP001)治疗慢性乙型肝炎患者2a期研究16周顶线中期结果, objectType=article, longId=215346, objectId=4dff215346ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dff215346ac, replyNumber=0, likeNumber=85, createdTime=2021-09-22, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dff215346ac, moduleTitle=ENYO Pharma发布进行中的两项Vonafexor (EYP001)治疗慢性乙型肝炎患者2a期研究16周顶线中期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dff215346ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825739, encodeId=09001825e391e, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=Dig Dis Sci:慢性乙型肝炎患者晚期肝纤维化与坏死性炎症相关与肝脂肪变性无关, objectType=article, longId=207199, objectId=582320e199b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=582320e199b9, replyNumber=0, likeNumber=66, createdTime=2022-01-20, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=582320e199b9, moduleTitle=Dig Dis Sci:慢性乙型肝炎患者晚期肝纤维化与坏死性炎症相关与肝脂肪变性无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=582320e199b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825744, encodeId=f3fa1825e44fd, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=Nat Commun：新型免疫疗法“高效”治疗乙型肝炎, objectType=article, longId=212544, objectId=3c272125442f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c272125442f, replyNumber=0, likeNumber=81, createdTime=2021-10-28, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c272125442f, moduleTitle=Nat Commun：新型免疫疗法“高效”治疗乙型肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c272125442f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825749, encodeId=171b1825e49e6, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=Hepatology International:糖尿病与乙型肝炎病毒相关性慢加急性肝衰竭患者的短期预后不良相关, objectType=article, longId=216570, objectId=d5bc2165e0ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5bc2165e0ab, replyNumber=0, likeNumber=131, createdTime=2021-09-03, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5bc2165e0ab, moduleTitle=Hepatology International:糖尿病与乙型肝炎病毒相关性慢加急性肝衰竭患者的短期预后不良相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5bc2165e0ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825736, encodeId=5c2f1825e36cb, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=AP&T: 乙型肝炎病毒RNA下降而无病毒性抗原下降与持续应答和乙型肝炎表面抗原丢失的可能性低相关, objectType=article, longId=205286, objectId=dda9205286e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dda9205286e9, replyNumber=0, likeNumber=80, createdTime=2021-03-23, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dda9205286e9, moduleTitle=AP&T: 乙型肝炎病毒RNA下降而无病毒性抗原下降与持续应答和乙型肝炎表面抗原丢失的可能性低相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dda9205286e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825738, encodeId=b6461825e386e, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=2021 USPSTF建议：青少年和成人乙型肝炎病毒感染筛查建议声明, objectType=article, longId=206854, objectId=2d28206854b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d28206854b0, replyNumber=0, likeNumber=72, createdTime=2021-11-23, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d28206854b0, moduleTitle=2021 USPSTF建议：青少年和成人乙型肝炎病毒感染筛查建议声明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d28206854b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825734, encodeId=382e1825e34e6, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=Clin Gastroenterology H：恩替卡韦与替诺福韦治疗慢性乙型肝炎病毒感染的肝细胞癌发生率方面无差异, objectType=article, longId=203042, objectId=810d20304236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810d20304236, replyNumber=0, likeNumber=97, createdTime=2021-02-09, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810d20304236, moduleTitle=Clin Gastroenterology H：恩替卡韦与替诺福韦治疗慢性乙型肝炎病毒感染的肝细胞癌发生率方面无差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810d20304236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825742, encodeId=d47f1825e42bb, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=腾盛博药、Vir Biotechnology和VBI Vaccines宣布启动BRII-835 (VIR-2218)联合BRII-179 (VBI-2601)治疗乙型肝炎的2期临床试验, objectType=article, longId=210372, objectId=3bb22103e2fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bb22103e2fc, replyNumber=0, likeNumber=73, createdTime=2022-03-05, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bb22103e2fc, moduleTitle=腾盛博药、Vir Biotechnology和VBI Vaccines宣布启动BRII-835 (VIR-2218)联合BRII-179 (VBI-2601)治疗乙型肝炎的2期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bb22103e2fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825741, encodeId=65951825e41bd, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率, objectType=article, longId=209258, objectId=9b01209258ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b01209258ab, replyNumber=0, likeNumber=69, createdTime=2021-04-05, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b01209258ab, moduleTitle=Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b01209258ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825745, encodeId=62291825e450a, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, objectType=article, longId=214297, objectId=744721429ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744721429ee4, replyNumber=0, likeNumber=70, createdTime=2022-05-14, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744721429ee4, moduleTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744721429ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825730, encodeId=c9cb1825e300a, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=Clinica Chimica Acta：乙型肝炎病毒基因型的抗乙型肝炎疫苗单克隆抗体的免疫反应模式, objectType=article, longId=199102, objectId=1814199102b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1814199102b3, replyNumber=0, likeNumber=60, createdTime=2021-01-25, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1814199102b3, moduleTitle=Clinica Chimica Acta：乙型肝炎病毒基因型的抗乙型肝炎疫苗单克隆抗体的免疫反应模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1814199102b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825728, encodeId=1f3b1825e284c, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低, objectType=article, longId=197180, objectId=5d3919e180a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d3919e180a1, replyNumber=0, likeNumber=64, createdTime=2020-09-27, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d3919e180a1, moduleTitle=AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d3919e180a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825731, encodeId=817b1825e3192, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=World J Gastroenterology: 营养状况和营养支持在乙型肝炎病毒相关的慢性慢性肝衰竭中的作用, objectType=article, longId=200985, objectId=681a200985d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=681a200985d7, replyNumber=0, likeNumber=89, createdTime=2021-03-15, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=681a200985d7, moduleTitle=World J Gastroenterology: 营养状况和营养支持在乙型肝炎病毒相关的慢性慢性肝衰竭中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=681a200985d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825726, encodeId=b8c71825e2654, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=它是乙型肝炎的“始作俑者”, objectType=article, longId=196758, objectId=befd196e5865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=befd196e5865, replyNumber=0, likeNumber=92, createdTime=2020-10-18, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=befd196e5865, moduleTitle=它是乙型肝炎的“始作俑者”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=befd196e5865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825727, encodeId=bba41825e27ef, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=AP&T:慢性乙型肝炎患者队列中的疾病合并症随时间增加, objectType=article, longId=197150, objectId=f49919e1509f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49919e1509f, replyNumber=0, likeNumber=78, createdTime=2021-04-10, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49919e1509f, moduleTitle=AP&T:慢性乙型肝炎患者队列中的疾病合并症随时间增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f49919e1509f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825737, encodeId=4e511825e3702, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, objectType=article, longId=206053, objectId=87a720605372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87a720605372, replyNumber=0, likeNumber=97, createdTime=2021-05-10, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87a720605372, moduleTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87a720605372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825732, encodeId=980a1825e3268, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=AP&T: ALT水平低的慢性乙型肝炎患者发生重大肝脏炎症的可能性非常低, objectType=article, longId=201012, objectId=e8152010122f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8152010122f, replyNumber=0, likeNumber=75, createdTime=2020-12-04, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8152010122f, moduleTitle=AP&T: ALT水平低的慢性乙型肝炎患者发生重大肝脏炎症的可能性非常低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8152010122f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825735, encodeId=704f1825e3537, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, objectType=article, longId=205090, objectId=009e20509087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009e20509087, replyNumber=0, likeNumber=79, createdTime=2021-09-27, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009e20509087, moduleTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=009e20509087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825724, encodeId=a3371825e2401, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=JVH：HBV pgRNA能够预测NAs抗病毒治疗慢性乙型肝炎患者的长期预后, objectType=article, longId=191009, objectId=8ee1191009e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ee1191009e3, replyNumber=0, likeNumber=88, createdTime=2020-12-01, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ee1191009e3, moduleTitle=JVH：HBV pgRNA能够预测NAs抗病毒治疗慢性乙型肝炎患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ee1191009e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825729, encodeId=b9e81825e296e, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, objectTitle=Hepatology:慢性乙型肝炎患者使用他汀类药物可降低肝细胞癌的风险, objectType=article, longId=197274, objectId=7a2819e27474, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2819e27474, replyNumber=0, likeNumber=67, createdTime=2020-10-20, rootId=0, userName=okhuali, userId=ea6321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2819e27474, moduleTitle=Hepatology:慢性乙型肝炎患者使用他汀类药物可降低肝细胞癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2819e27474)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乙型肝炎

2020-05-29

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

ENYO Pharma发布进行中的两项Vonafexor (EYP001)治疗慢性乙型肝炎患者2a期研究16周顶线中期结果

2021-09-22

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

Dig Dis Sci:慢性乙型肝炎患者晚期肝纤维化与坏死性炎症相关与肝脂肪变性无关

2022-01-20

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

Nat Commun：新型免疫疗法“高效”治疗乙型肝炎

2021-10-28

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

Hepatology International:糖尿病与乙型肝炎病毒相关性慢加急性肝衰竭患者的短期预后不良相关

2021-09-03

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

AP&T: 乙型肝炎病毒RNA下降而无病毒性抗原下降与持续应答和乙型肝炎表面抗原丢失的可能性低相关

2021-03-23

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

2021 USPSTF建议：青少年和成人乙型肝炎病毒感染筛查建议声明

2021-11-23

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

Clin Gastroenterology H：恩替卡韦与替诺福韦治疗慢性乙型肝炎病毒感染的肝细胞癌发生率方面无差异

2021-02-09

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

腾盛博药、Vir Biotechnology和VBI Vaccines宣布启动BRII-835 (VIR-2218)联合BRII-179 (VBI-2601)治疗乙型肝炎的2期临床试验

2022-03-05

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率

2021-04-05

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系

2022-05-14

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

Clinica Chimica Acta：乙型肝炎病毒基因型的抗乙型肝炎疫苗单克隆抗体的免疫反应模式

2021-01-25

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低

2020-09-27

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

World J Gastroenterology: 营养状况和营养支持在乙型肝炎病毒相关的慢性慢性肝衰竭中的作用

2021-03-15

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

它是乙型肝炎的“始作俑者”

2020-10-18

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

AP&T:慢性乙型肝炎患者队列中的疾病合并症随时间增加

2021-04-10

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况

2021-05-10

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

AP&T: ALT水平低的慢性乙型肝炎患者发生重大肝脏炎症的可能性非常低

2020-12-04

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究

2021-09-27

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

JVH：HBV pgRNA能够预测NAs抗病毒治疗慢性乙型肝炎患者的长期预后

2020-12-01

okhuali (审核中...)

前往app查看评论内容

#乙型肝炎#

Hepatology:慢性乙型肝炎患者使用他汀类药物可降低肝细胞癌的风险

2020-10-20

科室
- - 订阅+
  - 更多科室
工具
服务